Dr Reddys Laboratories Ltd Share Price Today - Live Blog for March 28, 2026

Dr Reddys Laboratories Ltd stock price decreased by -1.46%, with the current market value at 1281.70 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

Dr Reddys Laboratories Ltd share price has declined by -1.46%, and it's currently trading at 1281.70. The stock maintains a PE of 19.3700, while the industry PE is 31.9340, prompting discussions about its valuation.

With a -1.46% decrease, Dr Reddys Laboratories Ltd's share price is now at 1281.70. The stock is currently trading at a PE of 19.3700, while the industry PE is 31.9340, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd's share price has fallen by -1.46%, presenting both challenges and opportunities for investors. As of now, it's trading at 1281.70, and market participants are assessing the implications. The stock has a PE ratio of 19.3700, an ROE of 16.0277 and a debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd's share price has fallen by -1.46%, a situation worth noting. At present, the stock is trading at 1281.70. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 19.3700, while the industry PE ratio is 31.9340.

Dr Reddys Laboratories Ltd share price has declined by -1.46%, and it's currently trading at 1281.70. The stock maintains a PE of 19.3700, while the industry PE is 31.9340, prompting discussions about its valuation.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -1.46% in its share price, and it currently trades at 1281.70 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Dr Reddys Laboratories Ltd shares saw a decrease of -1.46%, reaching a current market price of 1281.70. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd stock price decreased by -1.46%, with the current market value at 1281.70 per share. Investors are assessing the stock's potential for recovery and future growth prospects.

The stock of Dr Reddys Laboratories Ltd suffered a -1.46% drop, and it's now trading at 1281.70 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -1.46% in its share price, and it currently trades at 1281.70 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.